SCHEMBL3109302

SCHEMBL3109302

Cc1ccc2c(c1)c(C(=O)C(=O)Nc1ccnc(Cl)c1)c(C(F)(F)F)n2Cc1ccc(Cl)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.65
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
SMARCA2 P51531 2/20 0.39
SMARCA4 P51532 2/20 0.39
MAPT P10636 3/20 0.38
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37
TUBB2A Q13885 1/20 0.37
TUBB8 Q3ZCM7 1/20 0.37
TUBA3E Q6PEY2 1/20 0.37
TUBA1A Q71U36 1/20 0.37
TUBA1C Q9BQE3 1/20 0.37
TUBB6 Q9BUF5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4089355 0.93 FAAH (0.65) FAAHMEN1HTTKMT2ASMARCA2
SCHEMBL3108612 0.93 FAAH (0.55) FAAHSMARCA2SMARCA4MAPTTUBB4A
SCHEMBL3105462 0.90 FAAH (0.53) FAAHMEN1KMT2ASMARCA2SMARCA4
SCHEMBL4090109 0.90 FAAH (0.61) FAAHMEN1HTTKMT2AMAPT
SCHEMBL3004476 0.90 FAAH (0.53) FAAHSMARCA2SMARCA4TP53THRB
SCHEMBL3003091 0.89 FAAH (0.58) FAAHMEN1HTTKMT2AMAPT
SCHEMBL4094223 0.89 FAAH (0.58) FAAHMEN1KMT2AMAPT
SCHEMBL4099212 0.89 FAAH (0.50) FAAHSMARCA2SMARCA4MAPTTUBB4A
SCHEMBL4095937 0.88 FAAH (0.53) FAAHSMARCA2SMARCA4MAPT
SCHEMBL2169121 0.88 FAAH (0.82) FAAHMEN1HTTKMT2ASMARCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
CN-102850324-A Indole compounds MICROBIA INC 2013-01-02 CN disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 FAAH 109/4885MEN1 3970/4885HTT 632/4885
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 FAAH 1/4885MEN1 4573/4885HTT 1985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.